Register
Community
Overview
Experts
Editors
Fellows
Code of conduct
AI Guidelines for Physicians
Company
About Us
FAQs
Privacy Policy
Terms of Use
Careers
Programs
News
News Releases
Press Coverage
Publications
Blog
Contact Us
Sign in
Please select the option that best describes you:
Topics:
General Internal Medicine
•
Hematology
•
Antiphospholipid Syndrome
•
Benign Hematology
How would you approach a patient with asymptomatic elevated PTT and positive lupus anticoagulant without history of thrombosis?
Would you test any other markers of antiphospholipid syndrome?
Related Questions
Can anti-cardiolipin or anti-beta-2 glycoprotein antibodies cause prolonged PTT in the absence of a lupus anticoagulant?
For patients with SLE, is there an ANC level for which you would hold or adjust hydroxychloroquine in an asymptomatic patient?
Are there any known contraindications or scenarios in which using antifibrinolytics would cause worsening of bleeding symptoms?
Can lupus anticoagulant be positive despite a normal aPTT?
What is your clinical threshold for treating a potential monoclonal gammopathy of thrombotic significance?
Are there data to support full-dose anticoagulation added to an antiplatelet in recurrent peripheral arterial thrombosis requiring revascularization and stenting?
Do you routinely check serum phosphorus levels after IV iron therapy?
Can TPO agonists, like avatrombopag or lusutrombopag, be used for patients with chronic thrombocytopenia and new acute portal vein thrombosis?
How long would you continue chronic transfusion therapy for adult sickle cell patients who have had a stroke?
In patients with lupus nephritis, and MAHA with positive anti-phospholipid autoantibodies, what are the considerations to use or not use anti-coagulation therapy?